Locoregional Stomach Cancer

Gastrointestinal Stromal Tumor

Male, 69 years

Patient Internal ID: 272447331

ICD-10 code

C16.8 Malignant Neoplasm of Overlapping Sites of Stomach

Diagnosis (Incl. Metastases/Stage) and Year

August 2019
Gastrointestinal Stromal Tumor (GIST) ypT4N0(0/12)M0 R0 LV0.

Previous Treatment

Target Therapy (Imatinib), Surgery.

Prognosis and Survival Expectation

The prognosis remains good, the overall 5-year relative survival rate for a GIST in the United States is 85%.

Treatment Provided

Autologous DCV (10 doses) over a period of 16 months.

Patient Survival/Condition and Year
Date of Review: 02/01/2024

The patient has survived for 54 months since the diagnosis and has no signs of disease. It can be concluded that the addition of Immunotherapy, alongside Target Therapy and Surgery, has benefited in disease stabilisation so far.